课题基金 / 基金详情

Mutagenicity/Genotoxicity with Endogenous PGH Synthase-2

Mutagenicity/Genotoxicity with Endogenous PGH Synthase-2
内源性 PGH 合酶 2 的致突变性/基因毒性
批准号:
6518251
负责人:
Hyesook Kim
金额:
$27.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2004-06-30

项目摘要

项目成果

Hyesook Kim的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):前列腺素H合酶(PGHS)起着重要的作用。 在炎症和致癌中起重要作用。PGHS表格2(PGHS-2) 由有丝分裂原、生长因子和肿瘤促进剂引起的致突变性, 遗传毒性细菌试验不适用,因为反应性毒物 PGHS-2产生的细菌毒素是短暂的,不能轻易地穿过细菌。 膜的 我们的目标是开发比色/荧光和荧光 实时定量PCR(QPCR)测定,以定量由 内源性人PGHS-2。在第一阶段,我们在人DNA中表达人PGHS-2, 修复缺陷型成纤维细胞系XPA用以下物质处理细胞 苯并(a)芘-7,8-二氢二醇,并通过16.2 kb的QPCR测量DNA损伤 使用比色/荧光测定法测定线粒体DNA。 在第二阶段,我们将改进比色/荧光QPCR检测 内部对照DNA并开发荧光实时QPCR测定。我们将 我还开发了QPCR检测与DNA损伤修复熟练的人成纤维细胞 用含有PGHS-2基因的载体转染细胞后的细胞系。 还将使用表达XPA的人PGHS-1开发QPCR试验。公用事业 将通过用几种不同的细胞处理细胞来探索这些测定法。 环境毒物 拟定商业应用: PGHS-2的表达增加可能导致包括结肠癌在内的人类肿瘤的发展。在真核细胞中表达的PGHS-2的可靠的致突变性和遗传毒性试验是非常需要的。因此,将使用人PGHS-2开发简便的比色/ECL和荧光实时定量PCR(QPCR)试验:在人DNA修复缺陷型和熟练型成纤维细胞中表达。QPCR检测试剂盒将上市,用于筛选PGHS-2依赖性前诱变剂和DNA损伤剂以及化学预防剂。
英文摘要
DESCRIPTION (provided by applicant): Prostaglandin H synthase (PGHS) plays a significant role in inflammation and carcinogenesis. PGHS form 2 (PGHS-2) induced by mitogens, growth factors and tumor promotors causes mutagenicity and genotoxicity. A bacterial test is not suitable because reactive toxicants produced by PGHS-2 are short-lived and cannot easily cross the bacterial membrane. Our objective is to develop colorimetric/chemiluminescent and fluorescent real-time quantitative PCR (QPCR) assays to quantitate DNA damage mediated by endogenous human PGHS-2. In Phase I, we expressed human PGHS-2 in human DNA repair deficient fibroblast cell line, XPA, treated the cells with benzo(a)pyrene-7,8-dihydrodiol and measured DNA damage by QPCR of 16.2 kb mitochondrial DNA using colorimetric/chemiluminescent assays. In Phase II, we will improve the colorimetric/chemiluminescent QPCR assay internal control DNAs and develop a fluorescent real-time QPCR assay. We will also develop QPCR assays with a DNA damage repair-proficient human fibroblast cell line after transfection of the cells with a PGHS-2 gene-containing vector. QPCR assays will also be developed with human PGHS-1 expressing XPA. Utilities of the assays will be explored by treatment of the cells with several environmental toxicants. PROPOSED COMMERCIAL APPLICATION: Increased expression of PGHS-2 may lead to development of human tumors including colon cancer. Reliable mutagenicity and genotoxicity assays with PGHS-2 expressed in eukaryotic cells is in great demand. Thus, facile colorimetric/ECL and fluorescent Real-Time quantitative PCR (QPCR) assays will be developed with human PGHS-2 :expressed in human DNA repair deficient and proficient fibroblasts. The QPCR assay kits will be marketed to screen PGHS-2-dependent promutagens and DNA damaging agents as well as chemopreventive agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glycoproteins and Glycan-Binding IgGs: Biomarkers for Cancer and Inflammatory Di
  • 批准号:
    8250520
  • 项目类别:
  • 资助金额:
    $15.29万
  • 财政年份:
    2012
  • 负责人:
    Hyesook Kim
  • 依托单位:
Glycoproteins and Glycan-Binding IgGs: Biomarkers for Cancer and Inflammatory Di
  • 批准号:
    8535687
  • 项目类别:
  • 资助金额:
    $14.09万
  • 财政年份:
    2012
  • 负责人:
    Hyesook Kim
  • 依托单位:
Targeted Antibody Microarrays:Tool for Toxicoproteomics
  • 批准号:
    7120162
  • 项目类别:
  • 资助金额:
    $27.53万
  • 财政年份:
    2005
  • 负责人:
    Hyesook Kim
  • 依托单位:
Targeted Antibody Microarrays:Tool for Toxicoproteomics
  • 批准号:
    6938769
  • 项目类别:
  • 资助金额:
    $46.26万
  • 财政年份:
    2005
  • 负责人:
    Hyesook Kim
  • 依托单位:
海外基金